Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
The Herbarium Hour cover art

The Herbarium Hour

The Herbarium Hour

Written by: Australian Institute of Pharmacognosy
Listen for free

About this listen

The Herbarium Hour is a weekly podcast on medicinal plants from the Australian Institute of Pharmacognosy in Cardwell, far north Queensland. Each episode takes one plant or one question and follows it through its history, its chemistry and what the research shows it can do.

The series covers herbal medicines used in Australia and around the world: echinacea, kava, pelargonium, turmeric, St John's wort, black cohosh and plenty more. We look at how they work in the body, how their quality is tested, what the TGA has decided about them and where the evidence stands. Ethnobotany and old herbals such as the Picatrix come into it too.

We're for herbal medicine, for education and for good science, and we think they belong together. The conversations are pitched so a curious listener can follow them without a science degree.

New episodes go out on Mondays at 09:00 AEST. Nothing in the show is a prescription or a dose. If you want to use a herb, consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy.

Australian Institute of Pharmacognosy, Cardwell, Queensland. https://www.australian-pharmacognosy.org/podcast/

AIP 2026
Alternative & Complementary Medicine Hygiene & Healthy Living Nature & Ecology Science
Episodes
  • Goat's Rue, Metformin and a Botanical Approach to Type 2 Diabetes
    Nov 15 2026

    Type 2 diabetes and the botanical consensus statement Dr Luke Iggulden wrote in 2016, starting with goat's rue (Galega officinalis), whose guanidine alkaloid galegine led chemists to metformin.

    The episode opens with the disease itself: insulin resistance in muscle, liver and fat, the TCF7L2 gene, and how fasting blood glucose, the oral glucose tolerance test and HbA1c are read, including why HbA1c alone can mislead in anaemia or kidney disease. It then runs through the main drug classes, from GLP-1 agonists such as semaglutide and the sulfonylureas to pioglitazone, the alpha-glucosidase blockers and metformin.

    Five core botanicals follow, each with its chemistry, ethanol strength for extraction and safety notes: goat's rue, Gymnema sylvestre and its gymnemic acids, fenugreek (Trigonella foenum-graecum) with 4-hydroxyisoleucine and seed mucilage, cinnamon (Cinnamomum verum) at 70% ethanol, and Phyllanthus amarus. Support for complications covers evening primrose oil for neuropathy, maitake and other beta-glucan mushrooms for immunity, bilberry (Vaccinium myrtillus) for retinopathy, milk thistle (Silybum marianum) for the liver, and ginger for circulation. It closes on the statement's case for herbalists and medical practitioners working together, with any change to prescribed medicine made jointly.

    In this episode: (00:00) Metformin and a garden weed; (01:45) What happens in type 2 diabetes; (07:12) Family history and the TCF7L2 gene; (09:25) FBG, OGTT and HbA1c; (14:13) GLP-1 agonists, sulfonylureas and pioglitazone; (16:34) Metformin, guanidine and goat's rue; (19:01) A low GI diet; (20:27) Antioxidants and oxidative stress; (23:50) Prebiotic fibre and the gut; (24:39) Meditation and forest bathing; (26:42) Cold percolation; (29:29) Dry extracts and coated tablets; (32:41) Goat's rue (Galega officinalis); (34:45) Gymnema sylvestre; (37:27) Fenugreek; (39:15) Cinnamon; (40:29) Phyllanthus amarus; (42:32) Neuropathy and evening primrose oil; (43:19) Immunity and medicinal mushrooms; (44:19) Retinopathy and bilberry; (45:01) The liver and milk thistle; (45:54) Circulation and the kidneys; (46:59) Conflict of interest and integrative care; (48:57) Herbs and drugs in combination; (51:36) Closing thought.

    About this episode: The Herbarium Hour is a third-party production based on the Institute's published papers. It is not produced in-house, and the hosts are not Institute staff. Where they get a technical detail wrong, the correction is listed here.

    Corrections. The podcast hosts misinterpreted the following from our papers:

    (00:28) The hosts said: Metformin is essentially an isolated compound from goat's rue. Correct: Metformin is a synthetic biguanide; it was developed from galegine, a guanidine alkaloid in goat's rue, and is not found in the plant itself.

    (02:01) The hosts said: The defining characteristic of type 2 diabetes is pancreatic beta cell insulin insensitivity. Correct: Type 2 diabetes is defined by insulin resistance in muscle, liver and fat cells together with a progressive decline in beta cell insulin secretion.

    Nothing in this episode is a prescription or a dose. If you want to use a herb, consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy.

    Dr Luke Iggulden, Chief Scientific Officer, wrote the 2016 botanical consensus statement the episode is based on and chose it for the show. Jesse Kirby, Head of Community Outreach, wrote the title, show notes, chapters and corrections from the episode transcript and scheduled the release.

    The Herbarium Hour, from the Australian Institute of Pharmacognosy, Cardwell, Queensland.

    Show More Show Less
    53 mins
  • Goat's Rue, Metformin and a Botanical Approach to Type 2 Diabetes
    Nov 8 2026

    Type 2 diabetes and the botanical consensus statement Dr Luke Iggulden wrote in 2016, starting with goat's rue (Galega officinalis), whose guanidine alkaloid galegine led chemists to metformin.

    The episode opens with the disease itself: insulin resistance in muscle, liver and fat, the TCF7L2 gene, and how fasting blood glucose, the oral glucose tolerance test and HbA1c are read, including why HbA1c alone can mislead in anaemia or kidney disease. It then runs through the main drug classes, from GLP-1 agonists such as semaglutide and the sulfonylureas to pioglitazone, the alpha-glucosidase blockers and metformin.

    Five core botanicals follow, each with its chemistry, ethanol strength for extraction and safety notes: goat's rue, Gymnema sylvestre and its gymnemic acids, fenugreek (Trigonella foenum-graecum) with 4-hydroxyisoleucine and seed mucilage, cinnamon (Cinnamomum verum) at 70% ethanol, and Phyllanthus amarus. Support for complications covers evening primrose oil for neuropathy, maitake and other beta-glucan mushrooms for immunity, bilberry (Vaccinium myrtillus) for retinopathy, milk thistle (Silybum marianum) for the liver, and ginger for circulation. It closes on the statement's case for herbalists and medical practitioners working together, with any change to prescribed medicine made jointly.

    In this episode: (00:00) Metformin and a garden weed; (01:45) What happens in type 2 diabetes; (07:12) Family history and the TCF7L2 gene; (09:25) FBG, OGTT and HbA1c; (14:13) GLP-1 agonists, sulfonylureas and pioglitazone; (16:34) Metformin, guanidine and goat's rue; (19:01) A low GI diet; (20:27) Antioxidants and oxidative stress; (23:50) Prebiotic fibre and the gut; (24:39) Meditation and forest bathing; (26:42) Cold percolation; (29:29) Dry extracts and coated tablets; (32:41) Goat's rue (Galega officinalis); (34:45) Gymnema sylvestre; (37:27) Fenugreek; (39:15) Cinnamon; (40:29) Phyllanthus amarus; (42:32) Neuropathy and evening primrose oil; (43:19) Immunity and medicinal mushrooms; (44:19) Retinopathy and bilberry; (45:01) The liver and milk thistle; (45:54) Circulation and the kidneys; (46:59) Conflict of interest and integrative care; (48:57) Herbs and drugs in combination; (51:36) Closing thought.

    About this episode: The Herbarium Hour is a third-party production based on the Institute's published papers. It is not produced in-house, and the hosts are not Institute staff. Where they get a technical detail wrong, the correction is listed here.

    Corrections. The podcast hosts misinterpreted the following from our papers:

    (00:28) The hosts said: Metformin is essentially an isolated compound from goat's rue. Correct: Metformin is a synthetic biguanide; it was developed from galegine, a guanidine alkaloid in goat's rue, and is not found in the plant itself.

    (02:01) The hosts said: The defining characteristic of type 2 diabetes is pancreatic beta cell insulin insensitivity. Correct: Type 2 diabetes is defined by insulin resistance in muscle, liver and fat cells together with a progressive decline in beta cell insulin secretion.

    Nothing in this episode is a prescription or a dose. If you want to use a herb, consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy.

    Dr Luke Iggulden, Chief Scientific Officer, wrote the 2016 botanical consensus statement the episode is based on and chose it for the show. Jesse Kirby, Head of Community Outreach, wrote the title, show notes, chapters and corrections from the episode transcript and scheduled the release.

    The Herbarium Hour, from the Australian Institute of Pharmacognosy, Cardwell, Queensland.

    Show More Show Less
    53 mins
  • Pelargonium sidoides: From the Cape to the Pharmacy Shelf
    Nov 1 2026

    Pelargonium sidoides, the South African root sold as umckaloabo, its tannins and coumarins, the EPs 7630 extract, and what an independent trial found when it was tested against usual care.

    The episode reads the Institute's 2026 Journal article. P. sidoides is a low, silver-leaved geranium of the summer-rainfall grasslands of the Eastern Cape and Lesotho, with a tuberous rootstock that carries it through frost, drought and fire; digging it kills the plant. Charles Henry Stevens brought a root decoction to Britain in 1897 and sold it without naming the plant. Adrien Sechehaye's Geneva case series of about 800 tuberculosis patients followed in the 1920s, and the source species, with P. reniforme alongside it, was identified in Munich in 1977. In 2010 the European Patent Office revoked Willmar Schwabe's extraction patent after oppositions that included the Masakhane community of the Tyhume Valley and the African Centre for Biosafety. It fell on lack of inventive step, so the benefit-sharing question went undecided.

    The Cochrane review (2008, updated 2013) graded the evidence for EPs 7630, an 11% ethanol liquid, as low quality in acute bronchitis and very low in sinusitis and the common cold, citing likely publication bias and manufacturer-sponsored trials; tablets did less well than the liquid. A 2026 open-label trial of 332 adults in Swiss primary care found no significant difference against usual care in time to halve symptom severity, with a trend to less antibiotic use, 17.4% against 25.2%. The last third covers red-flag symptoms and the one-week rule, the German liver warnings and the CIOMS reassessments in which none of 28 cases reached probable causality, its AUST R registration, the 2011 advisory committee minutes on a non-specific polyphenol assay, and what to check on the box.

    In this episode: (00:00) A brown bottle in the winter pharmacy aisle; (01:43) The article and its contradictions; (04:04) A geranium in witness protection; (05:40) Grasslands, frost and a 2,300 m range; (07:00) The tuber that survives fire; (07:42) Traditional use and the name umckaloabo; (08:40) Charles Henry Stevens and tuberculosis, 1897; (10:57) Sechehaye's 800 Geneva cases; (12:41) The plant is named in 1977; (13:51) Harvest kills the plant; (14:33) The Schwabe extraction patent; (15:39) The Masakhane community goes to Munich; (17:09) Revoked on inventive step; (18:42) Nagoya and provenance; (19:46) Wild harvest and cultivation; (21:07) Tannins and the pharmacopoeia standard; (22:44) Coumarins as the fingerprint; (23:26) Why these coumarins do not thin the blood; (25:40) In vitro against in vivo; (28:36) The Cochrane review and EPs 7630; (30:20) Low-quality evidence and sponsored trials; (31:11) Liquid against tablet; (32:27) The HATRIC feasibility study; (33:07) The 2026 Swiss primary care trial; (34:34) Fewer antibiotics?; (36:43) Red flags and the one-week rule; (38:35) Masking tuberculosis; (39:03) Side effects and allergy; (39:27) The German liver warnings; (39:54) Reassessing causality; (41:30) Why the warning stays; (42:16) Nose and gum bleeding; (43:41) How it reached Australian shelves: AUST R; (44:46) Export-only listings; (45:20) The 2011 committee minutes; (47:52) Has the evidence changed?; (49:15) What to check on the box; (51:13) Closing thought.

    Read more in the Institute's Journal: https://www.australian-pharmacognosy.org/blog/umckaloabo-pelargonium-sidoides-evidence-review/

    Nothing in this episode is a prescription or a dose. If you want to use a herb, consult a degree-qualified herbalist with competencies and adequate training in pharmacognosy.

    Dr Luke Iggulden, Chief Scientific Officer, made the episode from the Institute's Journal and monograph material. Jesse Kirby, Head of Community Outreach, wrote the show notes and chapters from the episode transcript.

    The Herbarium Hour, from the Australian Institute of Pharmacognosy, Cardwell, Queensland.

    Show More Show Less
    53 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet